Tesaglitazar

Tesaglitazar
Systematic (IUPAC) name
	(2S)-2-Ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
Identifiers
CAS Number	251565-85-2
ATC code	none
PubChem	CID: 208901
ChemSpider	180999
UNII	6734037O3L
KEGG	D01274
ChEMBL	CHEMBL521632
Chemical data
Formula	C20H24O7S
Molecular mass	408.46 g/mol
	SMILES CCO[C@@H](CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O ;
	InChI InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1 ; Key:CXGTZJYQWSUFET-IBGZPJMESA-N ;
(what is this?) (verify)

Tesaglitazar (also known as AZ 242) is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.^[1]

The drug had completed several phase III clinical trials,^[2] however in May, 2006 AstraZeneca announced that it had discontinued further development.^[3]

References

↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Lua error in package.lua at line 80: module 'strict' not found.^{[dead link]}
↑ Lua error in package.lua at line 80: module 'strict' not found.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.